What CMS is proposing for CY 2027 (MA + Part D)
CMS released its CY 2027 Advance Notice with “routine and technical” payment policy updates meant to improve payment accuracy and sustainability. If finalized, CMS projects a net average year-over-year MA […]
Broker Playbook: Protect Your Clients from Medicare Scams in 2026
TL;DR: Two 2025 headlines raised the baseline risk: (1) the Change Healthcare breach was updated to about 192.7M impacted individuals, and (2) unauthorized Medicare.gov accounts were created for some beneficiaries. […]
What Brokers Should Know About the 2027 Medicare Advantage & Part D Proposed Rule
Last month, CMS released the Contract Year (CY) 2027 Medicare Advantage and Part D Proposed Rule, a comprehensive set of policy and technical changes that, if finalized, would influence how […]
Major Updates to Medicare Plan Finder for 2026
The Centers for Medicare & Medicaid Services (CMS) has announced significant enhancements to Medicare Plan Finder (MPF) and Medicare.gov starting in Contract Year (CY) 2026. These changes are designed to […]
CMS Announces Medicare Advantage and Part D Proposed Rule for CY 2026: Key Impacts for Brokers and TPMOs
The Centers for Medicare & Medicaid Services (CMS) has announced the proposed rule for Contract Year (CY) 2026 affecting Medicare Advantage (MA) and Medicare Part D programs. These updates aim […]
CMS Issues New MBIs to Beneficiaries: What Brokers Need to Know
The Centers for Medicare and Medicaid Services (CMS) has started issuing new Medicare Beneficiary Identifiers (MBIs) to about 1.2 million beneficiaries. This update addresses specific cases where MBIs were compromised […]
Changes to Medicare in 2025 Affect Dual Eligible Special Needs Plans (D-SNPs)
Key Takeaways for Brokers The Centers for Medicare & Medicaid Services (CMS) has released the Medicare Final Rule for 2025, which includes significant changes that will impact Dual Eligible Special […]
Prescription Drug Plan (PDP) Compensation Updates
As 2025 approaches, significant changes are on the horizon for Prescription Drug Plans (PDPs), largely driven by the Inflation Reduction Act (IRA). These changes include the elimination of the Coverage Gap (or “donut hole”), a new $2,000 out-of-pocket spending cap, and adjustments in cost-sharing responsibilities during the catastrophic coverage phase.
In light of these shifts, Wellcare has made the difficult decision to cease new and renewal commissions for their PDP products starting January 1, 2025. Meanwhile, Aetna’s SilverScript Choice PDP will be offered as a non-commissionable product nationwide, with renewal commissions continuing on existing commissionable business.
Stay informed and prepared as these updates will impact your approach to PDP offerings in the upcoming year.
WellCare: Transitioning from Medicare Supplement to Medicare Advantage Crossover Training
Wellcare’s Business Acumen – Selling Against Medicare Supplement Join us as we dive into key topics:🔹 Annual price increases for PDP and Medicare Supplement🔹 The growing low-income population and its […]
CMS Announces 2025 Part D Bid & Premium Stabilization Demonstration Program
The Centers for Medicare & Medicaid Services (CMS) recently announced some exciting developments for Medicare Part D. On July 29, 2024, alongside preliminary 2025 Medicare Part D bid information, CMS […]